GOSS — Gossamer Bio Balance Sheet
0.000.00%
Last trade - 00:00
- $176.81m
- $89.40m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 402 | 513 | 325 | 256 | 296 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 409 | 522 | 332 | 262 | 307 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 15.7 | 16.1 | 10.8 | 9.89 | 4.78 |
Other Long Term Assets | |||||
Total Assets | 427 | 539 | 344 | 272 | 312 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Current Liabilities | 36.9 | 38.6 | 39.9 | 49.2 | 51.6 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 74.1 | 219 | 222 | 260 | 249 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 352 | 321 | 121 | 12.1 | 62.8 |
Total Liabilities & Shareholders' Equity | 427 | 539 | 344 | 272 | 312 |
Total Common Shares Outstanding |